Inflammation in age-related macular degeneration: Pathological or physiological?

Expert Review of Ophthalmology

Volumn 4, Issue 2, 2009, Pages 107-112

  Yasukawa, Tsutomu ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT FACTOR H; LIPID; LIPOFUSCIN; LIPOPROTEIN;

AGING; BRUCH MEMBRANE; DISEASE COURSE; DRUSEN; EDITORIAL; GENETIC POLYMORPHISM; GENOME ANALYSIS; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFLAMMATION; LIGHT EXPOSURE; LIPID METABOLISM; LIPID STORAGE; MACROPHAGE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHOTOTOXICITY; PIGMENT EPITHELIUM; PROTEIN TRANSPORT; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; SUBRETINAL NEOVASCULARIZATION;

EID: 69949175092     PISSN: 17469899     EISSN: 17469902     Source Type: Journal    
DOI: 10.1586/eop.09.1     Document Type: Editorial

References (44)

1. Klein R, Klein BE, Kinton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99, 933-943 (1992).
2. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population. Arch. Ophthalmol. 116, 653-658 (1998).
3. Bird AC, Bressler NM, Bressler SB et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The international ARM Epidemiological Study Group. Surv. Ophthalmol. 39, 367-374 (1995).
4. Killingworth MC. Age-related components of Bruch's membrane in the human eye. Graefes Arch. Clin. Exp. Ophthalmol. 225, 406-412 (1987).
5. Guymer R, Luthert P, Bird A. Changes in Bruch's membrane and related structures with age. Prog. Retin. Eye Res. 18, 59-90 (1999).
6. Hageman GS, Anderson DH, Johnson LV et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl Acad. Sci. USA 102, 7227-7232 (2005).
7. Klein RJ, Zeiss C, Chew EY et al. Complement factor H polymorphism in age-related macular degeneration. Science 308, 385-389 (2005).
8. Haines JL, Hauser MA, Schmidt S et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308, 419-421 (2005).
9. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 308, 421-424 (2005).
10. Yates JR, Sepp T, Matharu BK et al.; Genetic Factors in AMD Study Group. Complement C3 variant and the risk of age-related macular degeneration. N. Engl. J. Med. 357, 553-561 (2007).
11. Gold B, Merriam JE, Zernant J et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 38, 458-462 (2006).
12. Oh H, Takagi H, Takagi C et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest. Ophthalmol. Vis. Sci. 40, 1891-1898 (1999).
13. Kamei M, Yoneda K, Kume N et al. Scavenger receptors for oxidized lipoprotein in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 48, 1801-1807 (2007).
14. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res. 20, 705-732 (2001).
15. Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson DH. A potential role for immune complex pathogenesis in drusen formation. Exp. Eye Res. 70, 441-449 (2000).
16. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 134, 411-431 (2002).
17. Bok D. Evidence for an inflammatory process in age-related macular degeneration gains new support. Proc. Natl Acad. Sci. USA 102, 7053-7054 (2005).
18. Nozaki M, Raisler BJ, Sakurai E et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc. Natl Acad. Sci. USA 103, 2328-2333 (2006).
19. Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH. The Alzheimer's A β-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc. Natl Acad. Sci. USA 99, 11830-11835 (2002).
20. Anderson DH, Talaga KC, Rivest AJ, Barron E, Hageman GS, Johnson LV. Characterization of β amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp. Eye Res. 78, 243-256 (2004).
21. Guymer R, Robman L. Chlamydia pneumoniae and age-related macular degeneration: a role in pathogenesis or merely a chance association? Clin. Experiment. Ophthalmol. 35, 89-93 (2007).
22. Combadière C, Feumi C, Raoul W et al. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J. Clin. Invest. 117, 2920-2928 (2007).
23. Terasaki H, Miyake Y, Suzuki T, Nakamura M, Nagasaka T. Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation. Br. J. Ophthalmol. 86, 321-327 (2002).
24. Elner SG, Elner VM, Nielsen JC, Torczynski E, Yu R, Franklin WA. CD68 antigen expression by human retinal pigment epithelial cells. Exp. Eye Res. 55, 21-28 (1992).
25. Limb GA, Cole CJ, Earley O, Hollifield RD, Russell W, Stanford MR. Expression of hematopoietic cell markers by retinal pigment epithelial cells. Curr. Eye Res. 16, 985-991 (1997).
26. Itaya M, Sakurai E, Nozaki M et al. Upregulation of VEGF in murine retina via monocyte recruitment after retinal scatter laser photocoagulation. Invest. Ophthalmol. Vis. Sci. 48(12), 5677-5683 (2007).
27. Yin D. Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. Free Radical Biol. Med. 21, 871-888 (1996).
28. Okubo A, Rosa RH Jr, Bunce CV et al. The relationships of age changes in retinal pigment epithelium and Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 40, 443-449 (1999).
29. Schutt F, Bergmann M, Holz FG, Kopitz J. Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 44, 3663-3668 (2003).
30. Rózanowska M, Pawlak A, Rózanowski B et al. Age-related changes in the photo-reactivity of retinal lipofuscin granules: role of chloroform-insoluble components. Invest. Ophthalmol. Vis. Sci. 45, 1052-1060 (2004).
31. Moore DJ, Hussain AA, Marshall J. Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 36, 1290-1297 (1995).
32. Huang JD, Curcio CA, Johnson M. Morphometric ana lysis of lipoprotein-like particle accumulation in aging human macular Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 49, 2721-2727 (2008).
33. Evans JR. Risk factors for age-related macular degeneration. Prog. Retin. Eye Res. 20, 227-253 (2001).
34. Yasukawa T, Wiedemann P, Hoffmann S et al. Glycoxidized particles mimic lipofuscin accumulation in aging eyes: a new age-related macular degeneration model in rabbits. Graefes Arch. Clin. Exp. Ophthalmol. 245, 1475-1485 (2007).
35. van der Schaft TL, Mooy CM, de Bruijn WC, Wosman FT, de Jong PT. Immunohistochemical light and electron microscopy of basal laminar deposit. Graefes Arch. Clin. Exp. Ophthalmol. 232, 40-46 (1994).
36. Haimovici R, Gantz DL, Rumelt S, Freddo TF, Small DM. The lipid composition of drusen, Bruch's membrane, and sclera by hot stage polarizing light microscopy. Invest. Ophthalmol. Vis. Sci. 42, 1592-1599 (2001).
37. Curcio CA, Millican CL. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch. Ophthalmol. 117, 329-339 (1999).
38. Bressler SB, Maguire MG, Bressler NM, Fine SL; the Macular Photocoagulation Study Group. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. Arch. Ophthalmol. 108, 1442-1447 (1990).
39. Klein R, Klein BEK, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104, 7-21 (1997).
40. Malek G, Li C, Guidry C, Medeiros NE, Curcio CA. Apolipoprotein B in cholesterolcontaining drusen and basal deposits of human eyes with age-related maculopathy. Am. J. Pathol. 162, 413-425 (2003).
41. Li CM, Clark ME, Chimento MF, Curcio CA. Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression. Invest. Ophthalmol. Vis. Sci. 47, 3119-3128 (2006).
42. Wang L, Li CM, Rudolf M et al. Lipoprotein particles of intraocular origin in human Bruch membrane: an unusual lipid profile. Invest. Ophthalmol. Vis. Sci. 50, 870-877 (2009).
43. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 14, 835-846 (2000).
44. Yasukawa T, Wiedemann P, Takase A et al. Drusen formation in a three-dimensional culture system of retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 48, 2177 (2007).